Chemical leukoderma: when white patches trace back to a product you use

Most people meet the idea of pigment loss through vitiligo, an autoimmune condition that usually arrives without any obvious trigger. But a meaningful subset of white patches has a traceable cause sitting in a glove drawer, a hair dye box, a pair of shoes, or a cleaning cupboard. Chemical leukoderma, also called contact or occupational leukoderma, is depigmentation caused by repeated skin contact with specific compounds that are toxic to melanocytes, the cells that make pigment. It can look almost identical to vitiligo, it is frequently mistaken for vitiligo, and unlike vitiligo it sometimes stops once a single product is identified and removed.

A hazard first noticed at work. The condition entered the medical literature in 1939, when American physicians described tannery workers who developed white patches on their hands and forearms. The common thread was a new pair of rubber gloves. The antioxidant used in that rubber, monobenzyl ether of hydroquinone, turned out to be selectively destructive to pigment cells, a property later repurposed deliberately as depigmentation therapy for people with extensive vitiligo who want an even tone. That case set the template for everything since: an ordinary product, daily contact, and pigment loss exactly where the product touched.

The chemicals most often implicated. The known offenders cluster into a few chemical families, mostly phenols and catechols. Monobenzyl ether of hydroquinone and related compounds appear in some rubber goods and in skin lightening creams sold outside regulated markets. Para-tertiary butylphenol and para-tertiary butylcatechol are used in adhesives, resins, and plastics, and show up in leather goods, footwear, watch straps, and adhesive-backed accessories. Paraphenylenediamine, the dye base in most permanent hair color and in so-called black henna temporary tattoos, has been linked to depigmentation along the hairline and on the hands of both users and salon staff. Phenolic germicidal disinfectants used in hospitals and food plants belong on the list as well. A large clinical series from India that examined 864 cases of chemical leucoderma traced patches to specific everyday items, including adhesive bindis worn on the forehead, hair dyes, footwear, and deodorants, and reported that identifying and stopping the offending product was central to management (Ghosh and Mukhopadhyay, Br J Dermatol, 2009).

Why these particular chemicals. The pattern is not random. Most culprits are structurally similar to tyrosine, the amino acid that melanocytes use as the raw material for melanin. That resemblance lets them slip into the pigment-making machinery, where the enzyme tyrosinase converts them into reactive byproducts that generate oxidative stress inside the cell. In susceptible people the melanocyte is damaged or killed, and there is good evidence that the resulting cellular debris can also expose melanocyte proteins to the immune system, which is one proposed explanation for why patches sometimes appear far from the site of contact (Boissy and Manga, Pigment Cell Res, 2005). In other words, a chemical can start the process and immunity can carry it forward, which is why chemical leukoderma and autoimmune vitiligo are better understood as overlapping than as strictly separate.

How the pattern differs from ordinary vitiligo. The distribution is the biggest clue. Chemical leukoderma tends to begin precisely where the product sits: the forehead under an adhesive decoration, the hands and wrists under gloves or a watch strap, the tops of the feet in a specific pair of shoes, the hairline and scalp margin after coloring, the underarms after a deodorant change. Early lesions are often small, scattered, confetti-like white macules within the contact area rather than one large patch. Timing matters too, since patches typically follow weeks to months of repeated exposure rather than a single use. What chemical leukoderma does not do is announce itself, which is why so many cases are labeled idiopathic vitiligo until someone asks the right questions. Both the Mayo Clinic and the American Academy of Dermatology list exposure to certain chemicals among the recognized triggers for vitiligo-like pigment loss (Mayo Clinic, AAD).

Who is most at risk. Occupational exposure remains the classic setting: tannery and leather work, rubber and plastics manufacturing, adhesive and resin handling, printing, photographic processing, hospital and food-service cleaning, and hairdressing. Consumer exposure is broader and easier to miss, because the products are ordinary and the contact is habitual. Personal or family history of autoimmune disease appears to increase susceptibility, which fits the picture of a chemical insult landing on a predisposed immune system. Notably, only a minority of people with heavy exposure develop patches at all, so this is not a hazard that affects everyone equally.

What to do if you suspect it. The work is detective work, and a written timeline is the most useful first step. Note when the first patch appeared, then list every product that regularly touches that area of skin, including items that seem too mundane to matter, and pay attention to anything introduced in the two to six months beforehand. Bring that list to a dermatologist. Clinicians can confirm the extent of depigmentation with a Wood's lamp examination in a darkened room, distinguish it from a temporary process such as post-inflammatory hypopigmentation, and in some cases use patch testing to support a suspected chemical link, though a negative test does not rule the diagnosis out. The single most valuable intervention is removing the exposure, since continued contact keeps damaging pigment cells no matter what treatment is layered on top.

Treatment once exposure stops. After the trigger is removed, the toolkit is the same one used across vitiligo: topical anti-inflammatory and immune-modulating creams, topical JAK inhibitors, and narrowband UVB phototherapy to encourage surviving melanocytes to repopulate the skin. Response varies widely. Some people repigment substantially once the chemical is gone, others are left with stable patches that behave like long-standing vitiligo, and disease that has already spread beyond the original contact site tends to be more stubborn. Early recognition, as with nearly every pigment condition, buys the best odds.

Sensible prevention. If your work involves the chemical families above, treat gloves and protective equipment as non-negotiable and ask whether the material itself is a known offender, since substituting a different glove type is sometimes the entire fix. At home, be wary of imported skin lightening creams with unlabeled ingredients, avoid black henna temporary tattoos, and if you color your hair regularly, take any new pale spot at the hairline seriously rather than assuming it is sun damage. Anyone in a high-exposure trade who notices white spots should raise it with occupational health as well as a clinician, because a workplace case is rarely a single case.

The takeaway. Chemical leukoderma is the rare form of pigment loss with a cause you can sometimes name, hold in your hand, and throw away. That makes the history more valuable than any laboratory test. If you have developing white patches that map onto something you wear, apply, or handle every day, write down the timeline and see a dermatologist early, while stopping the exposure can still change the outcome.

Related reading: Vitiligo: what it is and how it is treated.